[Intradermal needling and acupuncture in prevention and treatment of leukopenia after chemotherapy with spleen-kidney deficiency: a randomized controlled trial].
Autor: | Hu H; College of TCM, Beijing University of CM, Beijing 100029, China., Yuan Z; Department of Oncology and Hematology, Third Affiliated Hospital, Beijing University of CM, Beijing 100029., Han L; Department of Oncology and Hematology, Third Affiliated Hospital, Beijing University of CM, Beijing 100029., Li T; Department of Oncology and Hematology, Third Affiliated Hospital, Beijing University of CM, Beijing 100029., Song F; Department of Oncology and Hematology, Third Affiliated Hospital, Beijing University of CM, Beijing 100029. |
---|---|
Jazyk: | čínština |
Zdroj: | Zhongguo zhen jiu = Chinese acupuncture & moxibustion [Zhongguo Zhen Jiu] 2024 Jun 12; Vol. 44 (6), pp. 631-6. |
DOI: | 10.13703/j.0255-2930.20231031-0003 |
Abstrakt: | Objective: To compare the clinical effect of intradermal needling and acupuncture in prevention and treatment of leukopenia after chemotherapy with spleen-kidney deficiency. Methods: A total of 90 patients with malignant tumor who received chemotherapy were randomly divided into a intradermal needling group (30 cases, 1 case dropped out), an acupuncture group (30 cases, 2 cases dropped out, 1 case was eliminated) and a control group (30 cases). The control group received conventional symptomatic treatment after chemotherapy. On the basis of the treatment in the control group, the intradermal needling group received intradermal needling at Guanyuan (CV 4), Dazhui (GV 14) and bilateral Geshu (BL 17), Zusanli (ST 36),Shenshu (BL 23), the needles were retained for 48 h, once every other day. On the basis of the treatment in the control group, the acupuncture group received conventional acupuncture at the same acupoints as the intradermal needling group, once every other day. The treatment started from the first day of chemotherapy, for a total of 2 weeks in the three groups. The white blood cell count, neutrophil count, hemoglobin content, platelet count and Karnofsky performance status (KPS) score before treatment and on 3rd, 7th, 14th, and 21st days after treatment were compared among the three groups. The incidence and grading of leukopenia and the usage of leukocyte-boosting drug during chemotherapy cycle was recorded. Results: On 7th day after treatment, the white blood cell count in the intradermal needling group and the acupuncture group was higher than that in the control group ( P <0.01, P <0.05). On the 14th day after treatment, the hemoglobin content in the intradermal needling group and the acupuncture group was higher than that in the control group ( P <0.01). On the 7th, 14th, and 21st days after treatment, the platelet count in the acupuncture group was higher than that in the control group ( P <0.01), on the 14th and 21st days after treatment, the platelet count in the intradermal needling group was higher than that in the control group ( P <0.01). There was no statistically significant difference among the three groups after treatment in terms of neutrophil count, KPS score, incidence and grading of leukopenia, and the usage of leukocyte-boosting drug ( P >0.05). Conclusion: Both intradermal needling and acupuncture can effectively increase peripheral blood white blood cell count, hemoglobin content and platelet count during chemotherapy cycle, reduce the toxicity of chemotherapy drug to bone marrow hematopoietic function, and alleviate bone marrow suppression after chemotherapy. The two treatments are equally effective. |
Databáze: | MEDLINE |
Externí odkaz: |